Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancers|May 16, 2023
Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and ColitisMiho Kono, Malek Shatila, Guofan Xu, et al.Journal of Cancer Research and Clinical Oncology|September 27, 2022
Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patientsAntony Mathew, Malek Shatila, Zongshan Lai, et al.Annals of Gastroenterology|September 5, 2022
Immune checkpoint inhibitor-related gastrointestinal toxicity in patients with malignancy involving the luminal gastrointestinal tract and its impact on cancer outcomesKevin Yu, Antony Mathew, Fiyinfoluwa Abraham, et al.Targeted Oncology|March 4, 2025
Differential Disease Behavior of Immune-Mediated Colitis Among Different Types of Immune Checkpoint InhibitionMalek Shatila, Farzin Eshaghi, Carolina Colli Cruz, et al.International Wound Journal|May 13, 2016
Closed incision negative pressure therapy: international multidisciplinary consensus recommendationsChristian Willy, Animesh Agarwal, Charles A Andersen, et al.Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.American Journal of Clinical Oncology|October 30, 2024
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal ToxicityJay Shah, Andres Caleb Urias Rivera, Irene Jeong-Ah Lee, et al.Circulation Research|April 12, 2023
Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular RemodelingSreenath Reddy Nayakanti, Aleksandra Friedrich, Poonam Sarode, et al.Nature Cardiovascular Research|August 28, 2024
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertensionFatemeh Khassafi, Prakash Chelladurai, Chanil Valasarajan, et al.Hepatology Communications|October 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational studyVincent Joerg, Bernhard Scheiner, Antonio D Alessio, et al.Pageof 4